The latest Fails news

Throwback Video: When Harry Bink Met Travis Pastrana

01/18/2019 09:07 pm - The post Throwback Video: When Harry Bink Met Travis Pastrana appeared first on Nitro Circus....

Ripping RZRs at Brimstone With Beaver Fleming

01/18/2019 07:08 pm - The post Ripping RZRs at Brimstone With Beaver Fleming appeared first on Nitro Circus....

AbbVie's Imbruvica fails to meet main goal in pancreatic cancer study

01/18/2019 06:49 pm - AbbVie Inc said on Friday its blockbuster cancer treatment in combination with chemotherapy agents failed to meet the main goal in a late-stage study of patients with a form of pancreatic cancer. ...

The 2019 Scooter Competition Season Is Already Lit

01/18/2019 06:07 pm - The post The 2019 Scooter Competition Season Is Already Lit appeared first on Nitro Circus....

Field Goal Fail: Fails of the Wee (January 2019)

01/18/2019 06:00 pm - ...

AbbVie's cancer drug fails to meet main goal in late-stage study

01/18/2019 05:52 pm - AbbVie Inc said on Friday its cancer treatment in combination with chemotherapy agents failed to meet the main goal in a late-stage study of patients with a form of pancreatic cancer. ...

Lilly cancer drug fails key trial, will no longer be prescribed

01/18/2019 02:52 pm - Eli Lilly and Co said on Friday that its cancer treatment Lartruvo, which had won conditional approval, failed to improve patient survival in a long-term confirmatory study and will no longer be prescribed, driving the drugmaker's shares down nearly 3 percent. ...

Lilly's cancer therapy Lartruvo fails study, shares drop

01/18/2019 08:30 am - Eli Lilly and Co said its cancer treatment Lartruvo failed to meet the main goal in a late-stage trial and it expects to take a charge in the first quarter of 2019, sending its shares down more than 2 percent in early trade. ...

Lilly's cancer therapy Lartruvo fails to meet main goal in late-stage trial

01/18/2019 08:22 am - Eli Lilly and Co said on Friday its cancer treatment Lartruvo failed to meet the main goal in a late-stage trial testing the therapy in patients with advanced or metastatic soft tissue sarcoma. ...

Immunomedics' cancer treatment fails to win accelerated approval from the FDA

01/17/2019 09:33 pm - Immunomedics Inc said on Thursday the U.S. Food and Drug Administration declined to grant accelerated approval for its breast cancer treatment, sacituzumab. ...